Loading...
Loading...
Protalix BioTherapeutics,
Inc.
PLX confirms, in response to inquiries received
this morning and a report appearing in the Israeli press, that the company has
engaged Citigroup to assist it in reviewing a broad array of product
partnering, technology sharing and other strategic alternatives. There is no
assurance that Protalix will undertake any such strategic alternative.
Protalix will not comment further on this initiative unless future events
would make doing so appropriate.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in